Long-term tacrine treatment in patients with Alzheimer's disease [21]

Lancet

Volumn 348, Issue 9022, 1996, Pages 275-276

  Solomon, P R ^a   Knapp, M J ^a   Gracon, S I ^a   Groccia, M ^a   Pendlebury, W W ^a  

^a WILLIAMS COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOOTROPIC AGENT; TACRINE;

ALZHEIMER DISEASE; CLINICAL ARTICLE; HUMAN; LETTER; PRIORITY JOURNAL;

EID: 0030055125     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)65594-8     Document Type: Letter

References (5)

1. K Amberla A Norberg Viitanen M B Winblad Long-term treatment with tacrine (THA) in Alzheimer's disease—evaluation of neuropsychological data Acta Neurol Scand suppl 149 1993 55 57
2. SA Eagger M Richards R Levy Long-term effects of tacrine in Alzheimer's disease: an open study Int J Geriatr Psychiatry 9 1994 643 647
3. MJ Knapp DS Knopman PR Solomon WW Pendlebury CS Davis SI Gracon A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease JAMA 271 1994 985 991
4. @) treatment: effect on nursing home placement and mortality. Neurology (in press).
5. GK Wilcock M Scott T Pearsall Long-term use of tacrine Lancet 343 1994 294